FDA rejects professor’s petition seeking to pull ‘dangerous’ Otsuka kidney disease drug
The FDA on Monday denied a petition from an emeritus professor at Ohio State University who had sought to revoke the approval of Otsuka’s kidney …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
